C
COYA THERAPEUTICS, INC. COMMON STOCK
NASDAQ: COYA (Coya Therapeutics, Inc.)
Kemas kini terakhir: 5 jam lalu5.08
-0.10 (-1.93%)
| Penutupan Terdahulu | 5.18 |
| Jumlah Dagangan | 59,938 |
| Harga / Jualan (P/S) | 13.15 |
| Harga / Buku (P/B) | 2.87 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -2,976.89% |
| EPS Cair (TTM) | -1.07 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 103.30% |
| Nisbah Semasa (MRQ) | 8.84 |
| Aliran Tunai Operasi (OCF TTM) | -15.26 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -10.29 M |
| Pulangan Atas Aset (ROA TTM) | -32.06% |
| Pulangan Atas Ekuiti (ROE TTM) | -52.11% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Coya Therapeutics, Inc. | Bercampur | Menurun |
AISkor Stockmoo
1.8
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.83 |
|
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 7.02% |
| % Dimiliki oleh Institusi | 28.08% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Dme Capital Management, Lp | 30 Jun 2026 | 2,335,540 |
| Alyeska Investment Group, L.P. | 30 Jun 2026 | 800,000 |
| Cm Management, Llc | 30 Jun 2026 | 400,000 |
| Private Management Group Inc | 30 Jun 2026 | 384,217 |
| Prosight Management, Lp | 30 Jun 2026 | 170,000 |
| Jones Financial Companies Lllp | 30 Jun 2026 | 110,910 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |